Adaptimmune Therapeutics plc ADAP
0.05 0.00 0.00%
As of Nov 21, 9:30 AM ET
0.0526 52-week range 0.0701
- YTD
- -91.00%
- 1 year
- -93.42%
- Open
- 0.0425
- Prev close
- 0.0485
- Mkt cap
- 75.16M
- Vol
- 1.68M
- Avg vol
- 127.15M
- EPS
- -0.65
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0425
- High
- 0.0599
- Forward P/E
- -1.52
- Beta
- 2.25
- Short ratio
- 4.71
- Inst. own
- 60.27%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.71418
- 200-d avg
- 1.03
- 1y target
- 2.27
MAX chart
Chart tools
Chart is warming up
The all-time price history for ADAP has not been loaded yet. Try again in a moment.
Altman Z-Score
-15.64 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
0 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -1.9×
P/S 0.8×
P/B 11.5×
P/FCF -1.8×
EV/EBITDA -2.2×
EV/Sales 0.7×
FCF Yield -55.9%
Gross Margin 100.0%
Operating Margin -38.6%
Net Margin -39.8%
ROE -597.6%
ROIC -36.9%
ROA -28.8%
Revenue 195.3%
Operating Income 50.2%
EPS (diluted) 50.4%
Free Cash Flow 47.9%
Current Ratio 2.9×
Quick Ratio 2.8×
Debt / Equity 6.3×
Net Debt / EBITDA 0.3×
Interest Coverage -20.5×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2024-12-31